Eloxx Pharmaceuticals, Inc. (ELOX)
OTCMKTS
· Delayed Price · Currency is USD
0.120
0.00 (0.00%)
At close: Apr 29, 2026
Eloxx Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 4.79 | 0.11 | 1.13 | 19.21 | 42.27 | Upgrade
|
| Cash & Short-Term Investments | 4.79 | 0.11 | 1.13 | 19.21 | 42.27 | Upgrade
|
| Cash Growth | 4210.81% | -90.21% | -94.10% | -54.56% | 71.35% | Upgrade
|
| Accounts Receivable | - | 2.36 | - | - | - | Upgrade
|
| Other Receivables | - | 0.36 | - | - | - | Upgrade
|
| Receivables | - | 2.72 | - | - | - | Upgrade
|
| Prepaid Expenses | 0.14 | 0.07 | 0.15 | 0.09 | 0.12 | Upgrade
|
| Restricted Cash | 0.01 | 0.01 | 0.22 | 0.26 | 0.3 | Upgrade
|
| Other Current Assets | 0.34 | 0.08 | 0.05 | 0.57 | 0.79 | Upgrade
|
| Total Current Assets | 5.27 | 2.98 | 1.55 | 20.13 | 43.48 | Upgrade
|
| Property, Plant & Equipment | - | - | 0.16 | 0.99 | 1.66 | Upgrade
|
| Total Assets | 5.27 | 2.98 | 1.71 | 21.12 | 45.14 | Upgrade
|
| Accounts Payable | 2.71 | 5.35 | 5.7 | 3.02 | 1.38 | Upgrade
|
| Accrued Expenses | 1.65 | 2 | 1.21 | 2.8 | 4.2 | Upgrade
|
| Short-Term Debt | 11.82 | 13.35 | 12.97 | 12.54 | 3.72 | Upgrade
|
| Current Portion of Long-Term Debt | 1 | 6.52 | 2.22 | 3.98 | - | Upgrade
|
| Current Portion of Leases | - | 0 | 0.13 | 0.71 | 0.66 | Upgrade
|
| Other Current Liabilities | - | 0.1 | 0.47 | 0.05 | - | Upgrade
|
| Total Current Liabilities | 17.18 | 27.31 | 22.7 | 23.09 | 9.96 | Upgrade
|
| Long-Term Debt | - | - | 1.61 | 8.56 | 12 | Upgrade
|
| Long-Term Leases | - | - | 0 | 0.14 | 0.8 | Upgrade
|
| Total Liabilities | 17.18 | 27.31 | 24.31 | 31.78 | 22.76 | Upgrade
|
| Common Stock | 0.05 | 0.04 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 288.63 | 270.22 | 268.81 | 263.71 | 262.88 | Upgrade
|
| Retained Earnings | -300.58 | -294.59 | -291.44 | -274.39 | -238.32 | Upgrade
|
| Treasury Stock | - | - | - | - | -2.19 | Upgrade
|
| Total Common Equity | -11.91 | -24.34 | -22.6 | -10.66 | 22.38 | Upgrade
|
| Shareholders' Equity | -11.91 | -24.34 | -22.6 | -10.66 | 22.38 | Upgrade
|
| Total Liabilities & Equity | 5.27 | 2.98 | 1.71 | 21.12 | 45.14 | Upgrade
|
| Total Debt | 12.82 | 19.87 | 16.93 | 25.92 | 17.18 | Upgrade
|
| Net Cash (Debt) | -8.03 | -19.76 | -15.8 | -6.71 | 25.09 | Upgrade
|
| Net Cash Growth | - | - | - | - | 112.14% | Upgrade
|
| Net Cash Per Share | -0.65 | -5.26 | -6.15 | -3.10 | 14.34 | Upgrade
|
| Filing Date Shares Outstanding | 5.07 | 3.76 | 2.57 | 2.17 | 2.17 | Upgrade
|
| Total Common Shares Outstanding | 4.79 | 3.76 | 2.57 | 2.17 | 2.17 | Upgrade
|
| Working Capital | -11.91 | -24.34 | -21.15 | -2.96 | 33.53 | Upgrade
|
| Book Value Per Share | -2.49 | -6.47 | -8.79 | -4.92 | 10.33 | Upgrade
|
| Tangible Book Value | -11.91 | -24.34 | -22.6 | -10.66 | 22.38 | Upgrade
|
| Tangible Book Value Per Share | -2.49 | -6.47 | -8.79 | -4.92 | 10.33 | Upgrade
|
| Machinery | - | - | 0.26 | 0.29 | 0.28 | Upgrade
|
| Construction In Progress | - | - | - | - | 0.02 | Upgrade
|
| Leasehold Improvements | - | - | 0.06 | 0.06 | 0.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.